SULF1 is also elevated in tumors with even greater fold-change compared to SULF2 and shows the same trends in terms of HPV infection; however, SULF2 is more strongly associated with the clinical outcomes of HNSCC patients defined by overall survival and progression-free interval. The gene discussed is SULF2; the disease is head and neck squamous cell carcinoma.